Gurinder Virdi serves as the Director of Product Management at goBalto, Inc., a pioneering company in the clinical trial space that was acquired by Oracle in January 2019. With over 12 years of experience in software product management and strategy, Gurinder has established himself as...
Gurinder Virdi serves as the Director of Product Management at goBalto, Inc., a pioneering company in the clinical trial space that was acquired by Oracle in January 2019. With over 12 years of experience in software product management and strategy, Gurinder has established himself as a leader in driving innovation through data analysis and strategic decision-making. His current role focuses on goBalto Select, a multi-tenant enterprise SaaS platform designed to enhance workflow management and data intelligence. This platform plays a crucial role in reducing site under-enrollment in clinical trials by identifying high-performing sites and population cohorts, thereby streamlining the recruitment process and improving trial outcomes.
Under Gurinder's leadership, the goBalto Select platform has seen significant enhancements, including the implementation of advanced analytics features that empower clinical trial sponsors to make data-driven decisions. His strategic vision has not only doubled the enterprise customer base but has also fostered a culture of continuous improvement and user-centric design within the product team. Gurinder’s expertise in EHR integration, project coordination, and employee training has been instrumental in aligning cross-functional teams towards common goals, ensuring that the product not only meets but exceeds user expectations.
In addition to his technical acumen, Gurinder is known for his strong communication and leadership skills, which have been pivotal in mentoring emerging talent within the organization. His passion for creating exceptional user experiences drives his commitment to delivering innovative solutions that address the evolving challenges in the clinical trial landscape. As goBalto continues to expand its footprint under Oracle, Gurinder remains at the forefront of shaping the future of clinical trial management through strategic product development and robust market insights.
